nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP3A4—bone cancer	0.484	1	CbGaD
Quetiapine—HTR1B—dura mater—bone cancer	0.0152	0.146	CbGeAlD
Quetiapine—HTR1D—dura mater—bone cancer	0.0148	0.141	CbGeAlD
Quetiapine—DRD5—eyelid—bone cancer	0.0145	0.139	CbGeAlD
Quetiapine—HTR1B—trigeminal nerve—bone cancer	0.00655	0.0628	CbGeAlD
Quetiapine—HTR1D—trigeminal nerve—bone cancer	0.00634	0.0608	CbGeAlD
Quetiapine—HTR3A—cranial nerve—bone cancer	0.00556	0.0533	CbGeAlD
Quetiapine—HRH1—nose—bone cancer	0.00481	0.0461	CbGeAlD
Quetiapine—HTR1B—cranial nerve—bone cancer	0.00467	0.0447	CbGeAlD
Quetiapine—HTR1D—cranial nerve—bone cancer	0.00452	0.0433	CbGeAlD
Quetiapine—HTR7—cranial nerve—bone cancer	0.0036	0.0345	CbGeAlD
Quetiapine—HTR2A—trigeminal nerve—bone cancer	0.00315	0.0302	CbGeAlD
Quetiapine—HTR2A—cranial nerve—bone cancer	0.00225	0.0215	CbGeAlD
Quetiapine—HTR2A—vertebral column—bone cancer	0.0022	0.0211	CbGeAlD
Quetiapine—HTR2A—hindlimb—bone cancer	0.00189	0.0181	CbGeAlD
Quetiapine—HTR2A—appendage—bone cancer	0.00162	0.0156	CbGeAlD
Quetiapine—H1F0—connective tissue—bone cancer	0.0012	0.0115	CbGeAlD
Quetiapine—HTR1D—connective tissue—bone cancer	0.000933	0.00894	CbGeAlD
Quetiapine—H1F0—tendon—bone cancer	0.000828	0.00793	CbGeAlD
Quetiapine—H1F0—bone marrow—bone cancer	0.000802	0.00768	CbGeAlD
Quetiapine—H1F0—spinal cord—bone cancer	0.000798	0.00765	CbGeAlD
Quetiapine—HTR7—connective tissue—bone cancer	0.000743	0.00712	CbGeAlD
Quetiapine—HTR1B—spinal cord—bone cancer	0.000639	0.00612	CbGeAlD
Quetiapine—HTR2C—spinal cord—bone cancer	0.000612	0.00587	CbGeAlD
Quetiapine—HRH1—connective tissue—bone cancer	0.000555	0.00531	CbGeAlD
Quetiapine—ADRA2A—connective tissue—bone cancer	0.000545	0.00522	CbGeAlD
Quetiapine—Mequitazine—CYP3A4—bone cancer	0.000543	0.164	CrCbGaD
Quetiapine—HTR1A—spinal cord—bone cancer	0.000515	0.00494	CbGeAlD
Quetiapine—HTR7—tendon—bone cancer	0.000511	0.00489	CbGeAlD
Quetiapine—HTR7—spinal cord—bone cancer	0.000492	0.00472	CbGeAlD
Quetiapine—ADRA2C—tendon—bone cancer	0.000469	0.0045	CbGeAlD
Quetiapine—HTR2A—connective tissue—bone cancer	0.000463	0.00444	CbGeAlD
Quetiapine—ADRA2C—spinal cord—bone cancer	0.000453	0.00434	CbGeAlD
Quetiapine—Nefazodone—CYP3A4—bone cancer	0.000446	0.135	CrCbGaD
Quetiapine—Olanzapine—CYP3A4—bone cancer	0.000427	0.129	CrCbGaD
Quetiapine—Trazodone—CYP3A4—bone cancer	0.000412	0.125	CrCbGaD
Quetiapine—Pipotiazine—CYP3A4—bone cancer	0.000386	0.117	CrCbGaD
Quetiapine—HRH1—tendon—bone cancer	0.000381	0.00365	CbGeAlD
Quetiapine—ADRA2A—tendon—bone cancer	0.000375	0.00359	CbGeAlD
Quetiapine—Prochlorperazine—CYP3A4—bone cancer	0.000369	0.112	CrCbGaD
Quetiapine—ADRA2A—spinal cord—bone cancer	0.000361	0.00346	CbGeAlD
Quetiapine—HTR2A—tendon—bone cancer	0.000318	0.00305	CbGeAlD
Quetiapine—HTR2A—spinal cord—bone cancer	0.000307	0.00294	CbGeAlD
Quetiapine—Sinusitis—Epirubicin—bone cancer	0.000275	0.00103	CcSEcCtD
Quetiapine—Hyperglycaemia—Doxorubicin—bone cancer	0.000274	0.00103	CcSEcCtD
Quetiapine—Agranulocytosis—Epirubicin—bone cancer	0.000273	0.00102	CcSEcCtD
Quetiapine—Pneumonia—Doxorubicin—bone cancer	0.000272	0.00102	CcSEcCtD
Quetiapine—Infestation—Doxorubicin—bone cancer	0.000271	0.00101	CcSEcCtD
Quetiapine—Infestation NOS—Doxorubicin—bone cancer	0.000271	0.00101	CcSEcCtD
Quetiapine—Visual impairment—Methotrexate—bone cancer	0.000271	0.00101	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000268	0.001	CcSEcCtD
Quetiapine—Hypersensitivity—Cisplatin—bone cancer	0.000268	0.001	CcSEcCtD
Quetiapine—Bradycardia—Epirubicin—bone cancer	0.000267	0.001	CcSEcCtD
Quetiapine—Erythema multiforme—Methotrexate—bone cancer	0.000265	0.000993	CcSEcCtD
Quetiapine—Perphenazine—CYP3A4—bone cancer	0.000264	0.0798	CrCbGaD
Quetiapine—Haemoglobin—Epirubicin—bone cancer	0.000264	0.000988	CcSEcCtD
Quetiapine—Stomatitis—Doxorubicin—bone cancer	0.000264	0.000988	CcSEcCtD
Quetiapine—Jaundice—Doxorubicin—bone cancer	0.000264	0.000988	CcSEcCtD
Quetiapine—Rhinitis—Epirubicin—bone cancer	0.000263	0.000986	CcSEcCtD
Quetiapine—Conjunctivitis—Doxorubicin—bone cancer	0.000263	0.000985	CcSEcCtD
Quetiapine—Urinary tract infection—Doxorubicin—bone cancer	0.000263	0.000985	CcSEcCtD
Quetiapine—Hepatitis—Epirubicin—bone cancer	0.000263	0.000983	CcSEcCtD
Quetiapine—Haemorrhage—Epirubicin—bone cancer	0.000263	0.000983	CcSEcCtD
Quetiapine—Eye disorder—Methotrexate—bone cancer	0.000262	0.000982	CcSEcCtD
Quetiapine—Tinnitus—Methotrexate—bone cancer	0.000262	0.000979	CcSEcCtD
Quetiapine—Hypoaesthesia—Epirubicin—bone cancer	0.000261	0.000978	CcSEcCtD
Quetiapine—Asthenia—Cisplatin—bone cancer	0.000261	0.000976	CcSEcCtD
Quetiapine—Pharyngitis—Epirubicin—bone cancer	0.000261	0.000976	CcSEcCtD
Quetiapine—Cardiac disorder—Methotrexate—bone cancer	0.000261	0.000975	CcSEcCtD
Quetiapine—Sweating—Doxorubicin—bone cancer	0.00026	0.000971	CcSEcCtD
Quetiapine—Urinary tract disorder—Epirubicin—bone cancer	0.000259	0.000971	CcSEcCtD
Quetiapine—Oedema peripheral—Epirubicin—bone cancer	0.000259	0.000968	CcSEcCtD
Quetiapine—Connective tissue disorder—Epirubicin—bone cancer	0.000258	0.000966	CcSEcCtD
Quetiapine—Urethral disorder—Epirubicin—bone cancer	0.000258	0.000964	CcSEcCtD
Quetiapine—Hepatobiliary disease—Doxorubicin—bone cancer	0.000256	0.000958	CcSEcCtD
Quetiapine—Epistaxis—Doxorubicin—bone cancer	0.000255	0.000956	CcSEcCtD
Quetiapine—Angiopathy—Methotrexate—bone cancer	0.000255	0.000953	CcSEcCtD
Quetiapine—Sinusitis—Doxorubicin—bone cancer	0.000254	0.000951	CcSEcCtD
Quetiapine—Immune system disorder—Methotrexate—bone cancer	0.000254	0.000949	CcSEcCtD
Quetiapine—Visual impairment—Epirubicin—bone cancer	0.000253	0.000947	CcSEcCtD
Quetiapine—Mediastinal disorder—Methotrexate—bone cancer	0.000253	0.000947	CcSEcCtD
Quetiapine—Agranulocytosis—Doxorubicin—bone cancer	0.000253	0.000946	CcSEcCtD
Quetiapine—Chills—Methotrexate—bone cancer	0.000252	0.000943	CcSEcCtD
Quetiapine—Diarrhoea—Cisplatin—bone cancer	0.000249	0.000931	CcSEcCtD
Quetiapine—Erythema multiforme—Epirubicin—bone cancer	0.000248	0.000929	CcSEcCtD
Quetiapine—Bradycardia—Doxorubicin—bone cancer	0.000247	0.000926	CcSEcCtD
Quetiapine—Mental disorder—Methotrexate—bone cancer	0.000246	0.00092	CcSEcCtD
Quetiapine—Eye disorder—Epirubicin—bone cancer	0.000245	0.000919	CcSEcCtD
Quetiapine—Tinnitus—Epirubicin—bone cancer	0.000245	0.000917	CcSEcCtD
Quetiapine—Malnutrition—Methotrexate—bone cancer	0.000244	0.000914	CcSEcCtD
Quetiapine—Haemoglobin—Doxorubicin—bone cancer	0.000244	0.000914	CcSEcCtD
Quetiapine—Cardiac disorder—Epirubicin—bone cancer	0.000244	0.000912	CcSEcCtD
Quetiapine—Rhinitis—Doxorubicin—bone cancer	0.000244	0.000912	CcSEcCtD
Quetiapine—Haemorrhage—Doxorubicin—bone cancer	0.000243	0.00091	CcSEcCtD
Quetiapine—Hepatitis—Doxorubicin—bone cancer	0.000243	0.00091	CcSEcCtD
Quetiapine—Hypoaesthesia—Doxorubicin—bone cancer	0.000242	0.000905	CcSEcCtD
Quetiapine—Pharyngitis—Doxorubicin—bone cancer	0.000241	0.000903	CcSEcCtD
Quetiapine—Urinary tract disorder—Doxorubicin—bone cancer	0.00024	0.000898	CcSEcCtD
Quetiapine—Oedema peripheral—Doxorubicin—bone cancer	0.000239	0.000896	CcSEcCtD
Quetiapine—Dysgeusia—Methotrexate—bone cancer	0.000239	0.000895	CcSEcCtD
Quetiapine—Connective tissue disorder—Doxorubicin—bone cancer	0.000239	0.000894	CcSEcCtD
Quetiapine—Angiopathy—Epirubicin—bone cancer	0.000238	0.000892	CcSEcCtD
Quetiapine—Urethral disorder—Doxorubicin—bone cancer	0.000238	0.000892	CcSEcCtD
Quetiapine—Promazine—CYP3A4—bone cancer	0.000238	0.0719	CrCbGaD
Quetiapine—Immune system disorder—Epirubicin—bone cancer	0.000237	0.000888	CcSEcCtD
Quetiapine—Mediastinal disorder—Epirubicin—bone cancer	0.000237	0.000886	CcSEcCtD
Quetiapine—Back pain—Methotrexate—bone cancer	0.000236	0.000885	CcSEcCtD
Quetiapine—Chills—Epirubicin—bone cancer	0.000236	0.000882	CcSEcCtD
Quetiapine—Visual impairment—Doxorubicin—bone cancer	0.000234	0.000877	CcSEcCtD
Quetiapine—Vomiting—Cisplatin—bone cancer	0.000231	0.000865	CcSEcCtD
Quetiapine—Vision blurred—Methotrexate—bone cancer	0.00023	0.000862	CcSEcCtD
Quetiapine—Mental disorder—Epirubicin—bone cancer	0.00023	0.000861	CcSEcCtD
Quetiapine—Erythema multiforme—Doxorubicin—bone cancer	0.00023	0.00086	CcSEcCtD
Quetiapine—Rash—Cisplatin—bone cancer	0.000229	0.000858	CcSEcCtD
Quetiapine—Dermatitis—Cisplatin—bone cancer	0.000229	0.000857	CcSEcCtD
Quetiapine—Malnutrition—Epirubicin—bone cancer	0.000229	0.000856	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—bone cancer	0.000227	0.00085	CcSEcCtD
Quetiapine—Ill-defined disorder—Methotrexate—bone cancer	0.000227	0.000848	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—bone cancer	0.000227	0.000848	CcSEcCtD
Quetiapine—Anaemia—Methotrexate—bone cancer	0.000226	0.000845	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—bone cancer	0.000226	0.000844	CcSEcCtD
Quetiapine—Flatulence—Epirubicin—bone cancer	0.000225	0.000843	CcSEcCtD
Quetiapine—Tension—Epirubicin—bone cancer	0.000224	0.00084	CcSEcCtD
Quetiapine—Dysgeusia—Epirubicin—bone cancer	0.000224	0.000838	CcSEcCtD
Quetiapine—Clozapine—CYP3A4—bone cancer	0.000223	0.0673	CrCbGaD
Quetiapine—Nervousness—Epirubicin—bone cancer	0.000222	0.000831	CcSEcCtD
Quetiapine—Back pain—Epirubicin—bone cancer	0.000221	0.000828	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—bone cancer	0.000221	0.000825	CcSEcCtD
Quetiapine—Malaise—Methotrexate—bone cancer	0.00022	0.000825	CcSEcCtD
Quetiapine—Muscle spasms—Epirubicin—bone cancer	0.00022	0.000823	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—bone cancer	0.00022	0.000822	CcSEcCtD
Quetiapine—Vertigo—Methotrexate—bone cancer	0.00022	0.000822	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—bone cancer	0.000219	0.00082	CcSEcCtD
Quetiapine—Leukopenia—Methotrexate—bone cancer	0.000219	0.000819	CcSEcCtD
Quetiapine—Chills—Doxorubicin—bone cancer	0.000218	0.000816	CcSEcCtD
Quetiapine—Nausea—Cisplatin—bone cancer	0.000216	0.000808	CcSEcCtD
Quetiapine—Vision blurred—Epirubicin—bone cancer	0.000216	0.000807	CcSEcCtD
Quetiapine—Cough—Methotrexate—bone cancer	0.000213	0.000798	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—bone cancer	0.000213	0.000797	CcSEcCtD
Quetiapine—Ill-defined disorder—Epirubicin—bone cancer	0.000212	0.000794	CcSEcCtD
Quetiapine—Convulsion—Methotrexate—bone cancer	0.000212	0.000792	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—bone cancer	0.000212	0.000792	CcSEcCtD
Quetiapine—Anaemia—Epirubicin—bone cancer	0.000211	0.000791	CcSEcCtD
Quetiapine—Agitation—Epirubicin—bone cancer	0.00021	0.000786	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—bone cancer	0.000208	0.00078	CcSEcCtD
Quetiapine—Myalgia—Methotrexate—bone cancer	0.000208	0.000779	CcSEcCtD
Quetiapine—Chest pain—Methotrexate—bone cancer	0.000208	0.000779	CcSEcCtD
Quetiapine—Arthralgia—Methotrexate—bone cancer	0.000208	0.000779	CcSEcCtD
Quetiapine—Tension—Doxorubicin—bone cancer	0.000208	0.000777	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—bone cancer	0.000207	0.000775	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000207	0.000773	CcSEcCtD
Quetiapine—Malaise—Epirubicin—bone cancer	0.000206	0.000772	CcSEcCtD
Quetiapine—Discomfort—Methotrexate—bone cancer	0.000206	0.000769	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—bone cancer	0.000206	0.000769	CcSEcCtD
Quetiapine—Vertigo—Epirubicin—bone cancer	0.000205	0.000769	CcSEcCtD
Quetiapine—Syncope—Epirubicin—bone cancer	0.000205	0.000767	CcSEcCtD
Quetiapine—Leukopenia—Epirubicin—bone cancer	0.000205	0.000766	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—bone cancer	0.000205	0.000766	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—bone cancer	0.000203	0.000761	CcSEcCtD
Quetiapine—ABCB1—bone marrow—bone cancer	0.000202	0.00194	CbGeAlD
Quetiapine—Palpitations—Epirubicin—bone cancer	0.000202	0.000756	CcSEcCtD
Quetiapine—ABCB1—spinal cord—bone cancer	0.000201	0.00193	CbGeAlD
Quetiapine—Confusional state—Methotrexate—bone cancer	0.000201	0.000753	CcSEcCtD
Quetiapine—Loss of consciousness—Epirubicin—bone cancer	0.000201	0.000752	CcSEcCtD
Quetiapine—Cough—Epirubicin—bone cancer	0.0002	0.000747	CcSEcCtD
Quetiapine—Anaphylactic shock—Methotrexate—bone cancer	0.000199	0.000746	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—bone cancer	0.000199	0.000746	CcSEcCtD
Quetiapine—Convulsion—Epirubicin—bone cancer	0.000198	0.000741	CcSEcCtD
Quetiapine—Infection—Methotrexate—bone cancer	0.000198	0.000741	CcSEcCtD
Quetiapine—Hypertension—Epirubicin—bone cancer	0.000197	0.000739	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—bone cancer	0.000196	0.000735	CcSEcCtD
Quetiapine—Nervous system disorder—Methotrexate—bone cancer	0.000196	0.000732	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—bone cancer	0.000196	0.000732	CcSEcCtD
Quetiapine—Thrombocytopenia—Methotrexate—bone cancer	0.000195	0.000731	CcSEcCtD
Quetiapine—Chest pain—Epirubicin—bone cancer	0.000195	0.000729	CcSEcCtD
Quetiapine—Myalgia—Epirubicin—bone cancer	0.000195	0.000729	CcSEcCtD
Quetiapine—Arthralgia—Epirubicin—bone cancer	0.000195	0.000729	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—bone cancer	0.000194	0.000728	CcSEcCtD
Quetiapine—Anxiety—Epirubicin—bone cancer	0.000194	0.000726	CcSEcCtD
Quetiapine—Skin disorder—Methotrexate—bone cancer	0.000194	0.000725	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000193	0.000724	CcSEcCtD
Quetiapine—Hyperhidrosis—Methotrexate—bone cancer	0.000193	0.000721	CcSEcCtD
Quetiapine—Discomfort—Epirubicin—bone cancer	0.000192	0.00072	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—bone cancer	0.000191	0.000714	CcSEcCtD
Quetiapine—Dry mouth—Epirubicin—bone cancer	0.00019	0.000713	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—bone cancer	0.00019	0.000711	CcSEcCtD
Quetiapine—Anorexia—Methotrexate—bone cancer	0.00019	0.000711	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—bone cancer	0.00019	0.00071	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—bone cancer	0.000189	0.000709	CcSEcCtD
Quetiapine—Confusional state—Epirubicin—bone cancer	0.000188	0.000704	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—bone cancer	0.000187	0.0007	CcSEcCtD
Quetiapine—Anaphylactic shock—Epirubicin—bone cancer	0.000187	0.000698	CcSEcCtD
Quetiapine—Hypotension—Methotrexate—bone cancer	0.000186	0.000697	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—bone cancer	0.000186	0.000696	CcSEcCtD
Quetiapine—Infection—Epirubicin—bone cancer	0.000185	0.000694	CcSEcCtD
Quetiapine—Cough—Doxorubicin—bone cancer	0.000185	0.000691	CcSEcCtD
Quetiapine—Shock—Epirubicin—bone cancer	0.000184	0.000687	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—bone cancer	0.000183	0.000686	CcSEcCtD
Quetiapine—Nervous system disorder—Epirubicin—bone cancer	0.000183	0.000685	CcSEcCtD
Quetiapine—Thrombocytopenia—Epirubicin—bone cancer	0.000183	0.000684	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—bone cancer	0.000183	0.000684	CcSEcCtD
Quetiapine—Tachycardia—Epirubicin—bone cancer	0.000182	0.000682	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000182	0.00068	CcSEcCtD
Quetiapine—Skin disorder—Epirubicin—bone cancer	0.000181	0.000678	CcSEcCtD
Quetiapine—Hyperhidrosis—Epirubicin—bone cancer	0.00018	0.000675	CcSEcCtD
Quetiapine—Insomnia—Methotrexate—bone cancer	0.00018	0.000675	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—bone cancer	0.00018	0.000674	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—bone cancer	0.00018	0.000674	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—bone cancer	0.00018	0.000674	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—bone cancer	0.00018	0.000672	CcSEcCtD
Quetiapine—Paraesthesia—Methotrexate—bone cancer	0.000179	0.00067	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000179	0.000669	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—bone cancer	0.000178	0.000666	CcSEcCtD
Quetiapine—Anorexia—Epirubicin—bone cancer	0.000178	0.000666	CcSEcCtD
Quetiapine—Dyspnoea—Methotrexate—bone cancer	0.000178	0.000665	CcSEcCtD
Quetiapine—Somnolence—Methotrexate—bone cancer	0.000177	0.000663	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—bone cancer	0.000176	0.000659	CcSEcCtD
Quetiapine—Dyspepsia—Methotrexate—bone cancer	0.000176	0.000657	CcSEcCtD
Quetiapine—Hypotension—Epirubicin—bone cancer	0.000174	0.000653	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—bone cancer	0.000174	0.000652	CcSEcCtD
Quetiapine—Decreased appetite—Methotrexate—bone cancer	0.000173	0.000649	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—bone cancer	0.000173	0.000646	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000172	0.000644	CcSEcCtD
Quetiapine—Fatigue—Methotrexate—bone cancer	0.000172	0.000643	CcSEcCtD
Quetiapine—Infection—Doxorubicin—bone cancer	0.000172	0.000642	CcSEcCtD
Quetiapine—Pain—Methotrexate—bone cancer	0.000171	0.000638	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00017	0.000636	CcSEcCtD
Quetiapine—Shock—Doxorubicin—bone cancer	0.00017	0.000636	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—bone cancer	0.000169	0.000634	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—bone cancer	0.000169	0.000633	CcSEcCtD
Quetiapine—Insomnia—Epirubicin—bone cancer	0.000169	0.000632	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—bone cancer	0.000169	0.000631	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—bone cancer	0.000168	0.000628	CcSEcCtD
Quetiapine—Paraesthesia—Epirubicin—bone cancer	0.000168	0.000627	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—bone cancer	0.000167	0.000625	CcSEcCtD
Quetiapine—Dyspnoea—Epirubicin—bone cancer	0.000166	0.000623	CcSEcCtD
Quetiapine—Somnolence—Epirubicin—bone cancer	0.000166	0.000621	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—bone cancer	0.000165	0.000616	CcSEcCtD
Quetiapine—Feeling abnormal—Methotrexate—bone cancer	0.000164	0.000615	CcSEcCtD
Quetiapine—Dyspepsia—Epirubicin—bone cancer	0.000164	0.000615	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methotrexate—bone cancer	0.000163	0.00061	CcSEcCtD
Quetiapine—Decreased appetite—Epirubicin—bone cancer	0.000162	0.000607	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—bone cancer	0.000161	0.000604	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000161	0.000603	CcSEcCtD
Quetiapine—Fatigue—Epirubicin—bone cancer	0.000161	0.000602	CcSEcCtD
Quetiapine—Constipation—Epirubicin—bone cancer	0.00016	0.000597	CcSEcCtD
Quetiapine—Pain—Epirubicin—bone cancer	0.00016	0.000597	CcSEcCtD
Quetiapine—Abdominal pain—Methotrexate—bone cancer	0.000158	0.00059	CcSEcCtD
Quetiapine—Body temperature increased—Methotrexate—bone cancer	0.000158	0.00059	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000157	0.000589	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—bone cancer	0.000156	0.000584	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—bone cancer	0.000155	0.00058	CcSEcCtD
Quetiapine—Dyspnoea—Doxorubicin—bone cancer	0.000154	0.000576	CcSEcCtD
Quetiapine—Feeling abnormal—Epirubicin—bone cancer	0.000154	0.000576	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—bone cancer	0.000154	0.000575	CcSEcCtD
Quetiapine—Gastrointestinal pain—Epirubicin—bone cancer	0.000153	0.000571	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—bone cancer	0.000152	0.000569	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—bone cancer	0.00015	0.000562	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000149	0.000558	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—bone cancer	0.000149	0.000557	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—bone cancer	0.000148	0.000553	CcSEcCtD
Quetiapine—Pain—Doxorubicin—bone cancer	0.000148	0.000553	CcSEcCtD
Quetiapine—Abdominal pain—Epirubicin—bone cancer	0.000148	0.000552	CcSEcCtD
Quetiapine—Body temperature increased—Epirubicin—bone cancer	0.000148	0.000552	CcSEcCtD
Quetiapine—Hypersensitivity—Methotrexate—bone cancer	0.000147	0.00055	CcSEcCtD
Quetiapine—Asthenia—Methotrexate—bone cancer	0.000143	0.000535	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—bone cancer	0.000142	0.000533	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000141	0.000528	CcSEcCtD
Quetiapine—Pruritus—Methotrexate—bone cancer	0.000141	0.000528	CcSEcCtD
Quetiapine—Hypersensitivity—Epirubicin—bone cancer	0.000138	0.000515	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—bone cancer	0.000137	0.000511	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—bone cancer	0.000137	0.000511	CcSEcCtD
Quetiapine—Diarrhoea—Methotrexate—bone cancer	0.000136	0.000511	CcSEcCtD
Quetiapine—Asthenia—Epirubicin—bone cancer	0.000134	0.000501	CcSEcCtD
Quetiapine—Pruritus—Epirubicin—bone cancer	0.000132	0.000494	CcSEcCtD
Quetiapine—Dizziness—Methotrexate—bone cancer	0.000132	0.000494	CcSEcCtD
Quetiapine—Diarrhoea—Epirubicin—bone cancer	0.000128	0.000478	CcSEcCtD
Quetiapine—Hypersensitivity—Doxorubicin—bone cancer	0.000127	0.000476	CcSEcCtD
Quetiapine—Vomiting—Methotrexate—bone cancer	0.000127	0.000475	CcSEcCtD
Quetiapine—Rash—Methotrexate—bone cancer	0.000126	0.000471	CcSEcCtD
Quetiapine—Dermatitis—Methotrexate—bone cancer	0.000126	0.00047	CcSEcCtD
Quetiapine—Headache—Methotrexate—bone cancer	0.000125	0.000468	CcSEcCtD
Quetiapine—Asthenia—Doxorubicin—bone cancer	0.000124	0.000464	CcSEcCtD
Quetiapine—Dizziness—Epirubicin—bone cancer	0.000123	0.000462	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—bone cancer	0.000122	0.000457	CcSEcCtD
Quetiapine—Vomiting—Epirubicin—bone cancer	0.000119	0.000444	CcSEcCtD
Quetiapine—Nausea—Methotrexate—bone cancer	0.000118	0.000443	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—bone cancer	0.000118	0.000442	CcSEcCtD
Quetiapine—Rash—Epirubicin—bone cancer	0.000118	0.00044	CcSEcCtD
Quetiapine—Dermatitis—Epirubicin—bone cancer	0.000118	0.00044	CcSEcCtD
Quetiapine—Headache—Epirubicin—bone cancer	0.000117	0.000438	CcSEcCtD
Quetiapine—Dizziness—Doxorubicin—bone cancer	0.000114	0.000427	CcSEcCtD
Quetiapine—Nausea—Epirubicin—bone cancer	0.000111	0.000415	CcSEcCtD
Quetiapine—Vomiting—Doxorubicin—bone cancer	0.00011	0.000411	CcSEcCtD
Quetiapine—Rash—Doxorubicin—bone cancer	0.000109	0.000407	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—bone cancer	0.000109	0.000407	CcSEcCtD
Quetiapine—Headache—Doxorubicin—bone cancer	0.000108	0.000405	CcSEcCtD
Quetiapine—Nausea—Doxorubicin—bone cancer	0.000103	0.000384	CcSEcCtD
Quetiapine—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	2.1e-05	0.000149	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ENO2—bone cancer	2.1e-05	0.000149	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	2.07e-05	0.000146	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ATF1—bone cancer	2.04e-05	0.000145	CbGpPWpGaD
Quetiapine—ADRA2B—Hemostasis—TP53—bone cancer	2.04e-05	0.000145	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.04e-05	0.000145	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—MDM2—bone cancer	2.04e-05	0.000145	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—GSTP1—bone cancer	2.04e-05	0.000144	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.03e-05	0.000144	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—JUN—bone cancer	2e-05	0.000142	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—KIT—bone cancer	2e-05	0.000142	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—KIT—bone cancer	2e-05	0.000141	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL3—bone cancer	1.99e-05	0.000141	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—DHFR—bone cancer	1.99e-05	0.000141	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—KIT—bone cancer	1.98e-05	0.000141	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ENO2—bone cancer	1.98e-05	0.00014	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IGF1R—bone cancer	1.97e-05	0.00014	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—MMP9—bone cancer	1.95e-05	0.000138	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—DHFR—bone cancer	1.95e-05	0.000138	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IGF1R—bone cancer	1.94e-05	0.000138	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—KIT—bone cancer	1.94e-05	0.000138	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—KIT—bone cancer	1.91e-05	0.000135	CbGpPWpGaD
Quetiapine—ADRA2C—Hemostasis—TP53—bone cancer	1.91e-05	0.000135	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TGFBR2—bone cancer	1.9e-05	0.000135	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—KIT—bone cancer	1.89e-05	0.000134	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—BRAF—bone cancer	1.88e-05	0.000133	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—BRAF—bone cancer	1.88e-05	0.000133	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.87e-05	0.000133	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TGFBR2—bone cancer	1.87e-05	0.000132	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—GSTP1—bone cancer	1.87e-05	0.000132	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—BRAF—bone cancer	1.86e-05	0.000132	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	1.86e-05	0.000132	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—GNA11—bone cancer	1.86e-05	0.000132	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TGFBR2—bone cancer	1.86e-05	0.000132	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	1.84e-05	0.00013	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	1.83e-05	0.00013	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—DHFR—bone cancer	1.83e-05	0.00013	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—BRAF—bone cancer	1.83e-05	0.000129	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—EGFR—bone cancer	1.82e-05	0.000129	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—EGFR—bone cancer	1.82e-05	0.000129	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—GNA11—bone cancer	1.82e-05	0.000129	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—EGFR—bone cancer	1.81e-05	0.000128	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—KIT—bone cancer	1.81e-05	0.000128	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—BRAF—bone cancer	1.8e-05	0.000127	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IGF1R—bone cancer	1.79e-05	0.000127	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—JUN—bone cancer	1.77e-05	0.000126	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—BRAF—bone cancer	1.77e-05	0.000126	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—EGFR—bone cancer	1.77e-05	0.000125	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.76e-05	0.000125	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IGF1R—bone cancer	1.76e-05	0.000125	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IGF1R—bone cancer	1.75e-05	0.000124	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IGF1R—bone cancer	1.75e-05	0.000124	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—EGFR—bone cancer	1.74e-05	0.000123	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IGF1R—bone cancer	1.73e-05	0.000123	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.73e-05	0.000122	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—MMP9—bone cancer	1.73e-05	0.000122	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—KIT—bone cancer	1.72e-05	0.000122	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—EGFR—bone cancer	1.72e-05	0.000122	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—GNA11—bone cancer	1.71e-05	0.000121	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	1.7e-05	0.000121	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—KIT—bone cancer	1.7e-05	0.00012	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—KIT—bone cancer	1.7e-05	0.00012	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—BRAF—bone cancer	1.7e-05	0.00012	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—CYP3A4—bone cancer	1.69e-05	0.00012	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.68e-05	0.000119	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—CYP3A4—bone cancer	1.65e-05	0.000117	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—EGFR—bone cancer	1.65e-05	0.000117	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—BRAF—bone cancer	1.62e-05	0.000115	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.6e-05	0.000114	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—BRAF—bone cancer	1.6e-05	0.000113	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—BRAF—bone cancer	1.6e-05	0.000113	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—EGFR—bone cancer	1.58e-05	0.000112	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—MDM2—bone cancer	1.57e-05	0.000112	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—MDM2—bone cancer	1.57e-05	0.000111	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—EGFR—bone cancer	1.57e-05	0.000111	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—MDM2—bone cancer	1.56e-05	0.000111	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.55e-05	0.00011	CbGpPWpGaD
Quetiapine—ADRA2A—Hemostasis—TP53—bone cancer	1.55e-05	0.00011	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—EGFR—bone cancer	1.55e-05	0.00011	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—EGFR—bone cancer	1.55e-05	0.00011	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KIT—bone cancer	1.53e-05	0.000109	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—MDM2—bone cancer	1.53e-05	0.000108	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—MDM2—bone cancer	1.51e-05	0.000107	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—MDM2—bone cancer	1.49e-05	0.000105	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KIT—bone cancer	1.48e-05	0.000105	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KIT—bone cancer	1.47e-05	0.000104	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—GSTP1—bone cancer	1.44e-05	0.000102	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.44e-05	0.000102	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KIT—bone cancer	1.43e-05	0.000101	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MDM2—bone cancer	1.42e-05	0.000101	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—GSTP1—bone cancer	1.41e-05	9.99e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KIT—bone cancer	1.41e-05	9.99e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.4e-05	9.9e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—EGFR—bone cancer	1.39e-05	9.88e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—BRAF—bone cancer	1.39e-05	9.86e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—BRAF—bone cancer	1.38e-05	9.81e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—JUN—bone cancer	1.37e-05	9.7e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—JUN—bone cancer	1.37e-05	9.69e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—JUN—bone cancer	1.36e-05	9.62e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MDM2—bone cancer	1.36e-05	9.6e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.35e-05	9.55e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—BRAF—bone cancer	1.35e-05	9.54e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.34e-05	9.5e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PTGS2—bone cancer	1.34e-05	9.49e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MDM2—bone cancer	1.34e-05	9.48e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.34e-05	9.48e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—MMP9—bone cancer	1.33e-05	9.43e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—MMP9—bone cancer	1.33e-05	9.42e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—JUN—bone cancer	1.33e-05	9.42e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—GSTP1—bone cancer	1.33e-05	9.41e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.32e-05	9.39e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—TP53—bone cancer	1.32e-05	9.37e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—MMP9—bone cancer	1.32e-05	9.36e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—JUN—bone cancer	1.31e-05	9.27e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.3e-05	9.24e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PTGS2—bone cancer	1.3e-05	9.21e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KIT—bone cancer	1.3e-05	9.21e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—MMP9—bone cancer	1.29e-05	9.17e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ENO2—bone cancer	1.29e-05	9.15e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—JUN—bone cancer	1.29e-05	9.15e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.28e-05	9.1e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KIT—bone cancer	1.28e-05	9.06e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KIT—bone cancer	1.28e-05	9.04e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—MMP9—bone cancer	1.27e-05	9.02e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KIT—bone cancer	1.27e-05	9.01e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KIT—bone cancer	1.27e-05	8.98e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—MMP9—bone cancer	1.26e-05	8.9e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KIT—bone cancer	1.26e-05	8.89e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KIT—bone cancer	1.25e-05	8.87e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—JUN—bone cancer	1.24e-05	8.76e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—BRAF—bone cancer	1.22e-05	8.65e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.21e-05	8.55e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MMP9—bone cancer	1.2e-05	8.52e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—BRAF—bone cancer	1.2e-05	8.51e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—BRAF—bone cancer	1.2e-05	8.5e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—DHFR—bone cancer	1.2e-05	8.49e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—BRAF—bone cancer	1.2e-05	8.47e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—BRAF—bone cancer	1.19e-05	8.44e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—EGFR—bone cancer	1.18e-05	8.39e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—BRAF—bone cancer	1.18e-05	8.36e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—JUN—bone cancer	1.18e-05	8.35e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.18e-05	8.34e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TP53—bone cancer	1.17e-05	8.29e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MDM2—bone cancer	1.17e-05	8.26e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.16e-05	8.25e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KIT—bone cancer	1.16e-05	8.24e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—JUN—bone cancer	1.16e-05	8.24e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—JUN—bone cancer	1.16e-05	8.24e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—EGFR—bone cancer	1.16e-05	8.23e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MDM2—bone cancer	1.16e-05	8.22e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—EGFR—bone cancer	1.16e-05	8.21e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—EGFR—bone cancer	1.15e-05	8.18e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTGS2—bone cancer	1.15e-05	8.15e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MMP9—bone cancer	1.15e-05	8.12e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.14e-05	8.1e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.14e-05	8.08e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MMP9—bone cancer	1.13e-05	8.01e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MMP9—bone cancer	1.13e-05	8.01e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MDM2—bone cancer	1.13e-05	7.99e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GNA11—bone cancer	1.12e-05	7.94e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.11e-05	7.86e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.09e-05	7.75e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—EGFR—bone cancer	1.08e-05	7.62e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—EGFR—bone cancer	1.07e-05	7.62e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—EGFR—bone cancer	1.07e-05	7.57e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.06e-05	7.51e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTGS2—bone cancer	1.06e-05	7.48e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—JUN—bone cancer	1.05e-05	7.44e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—EGFR—bone cancer	1.05e-05	7.41e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—EGFR—bone cancer	1.03e-05	7.29e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MDM2—bone cancer	1.02e-05	7.25e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.02e-05	7.23e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EGFR—bone cancer	1.02e-05	7.19e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—JUN—bone cancer	1.01e-05	7.18e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—JUN—bone cancer	1.01e-05	7.14e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MDM2—bone cancer	1.01e-05	7.13e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MDM2—bone cancer	1e-05	7.12e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MDM2—bone cancer	1e-05	7.1e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MDM2—bone cancer	9.98e-06	7.07e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MDM2—bone cancer	9.89e-06	7e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MDM2—bone cancer	9.86e-06	6.99e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MMP9—bone cancer	9.86e-06	6.98e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MMP9—bone cancer	9.81e-06	6.95e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—JUN—bone cancer	9.8e-06	6.95e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EGFR—bone cancer	9.72e-06	6.89e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—bone cancer	9.68e-06	6.86e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—JUN—bone cancer	9.65e-06	6.84e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MMP9—bone cancer	9.54e-06	6.76e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MMP9—bone cancer	9.39e-06	6.65e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—bone cancer	9.26e-06	6.56e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MDM2—bone cancer	9.16e-06	6.49e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—bone cancer	9.14e-06	6.48e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—bone cancer	9.14e-06	6.48e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—bone cancer	9.03e-06	6.4e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—bone cancer	9.02e-06	6.39e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—bone cancer	8.97e-06	6.35e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—JUN—bone cancer	8.9e-06	6.3e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—bone cancer	8.78e-06	6.22e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—JUN—bone cancer	8.75e-06	6.2e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—JUN—bone cancer	8.73e-06	6.19e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—JUN—bone cancer	8.71e-06	6.17e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTP1—bone cancer	8.69e-06	6.15e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—JUN—bone cancer	8.68e-06	6.15e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MMP9—bone cancer	8.65e-06	6.13e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—bone cancer	8.64e-06	6.12e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—JUN—bone cancer	8.59e-06	6.09e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—JUN—bone cancer	8.57e-06	6.07e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—bone cancer	8.52e-06	6.04e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MMP9—bone cancer	8.52e-06	6.03e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MMP9—bone cancer	8.5e-06	6.02e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MMP9—bone cancer	8.47e-06	6e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—bone cancer	8.44e-06	5.98e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—bone cancer	8.36e-06	5.92e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—bone cancer	8.34e-06	5.91e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—bone cancer	8.25e-06	5.85e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—bone cancer	8.16e-06	5.78e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—bone cancer	7.97e-06	5.64e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—JUN—bone cancer	7.96e-06	5.64e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—bone cancer	7.92e-06	5.61e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—bone cancer	7.78e-06	5.51e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—bone cancer	7.75e-06	5.49e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—bone cancer	7.71e-06	5.46e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—bone cancer	7.67e-06	5.44e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—bone cancer	7.67e-06	5.44e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—bone cancer	7.59e-06	5.37e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—bone cancer	7.48e-06	5.3e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—bone cancer	7.3e-06	5.17e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—bone cancer	6.99e-06	4.95e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—bone cancer	6.93e-06	4.91e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—bone cancer	6.88e-06	4.88e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—bone cancer	6.88e-06	4.88e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—bone cancer	6.87e-06	4.86e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—bone cancer	6.84e-06	4.85e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—bone cancer	6.82e-06	4.83e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—bone cancer	6.76e-06	4.79e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—bone cancer	6.74e-06	4.77e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—bone cancer	6.69e-06	4.74e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—bone cancer	6.65e-06	4.71e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—bone cancer	6.47e-06	4.58e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—bone cancer	6.37e-06	4.51e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—bone cancer	6.26e-06	4.44e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—bone cancer	5.87e-06	4.16e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—bone cancer	5.78e-06	4.09e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—bone cancer	5.77e-06	4.08e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—bone cancer	5.75e-06	4.07e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—bone cancer	5.73e-06	4.06e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—bone cancer	5.67e-06	4.02e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—bone cancer	5.66e-06	4.01e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—bone cancer	5.26e-06	3.72e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—bone cancer	4.5e-06	3.19e-05	CbGpPWpGaD
